Research view
Switch to patient viewColorectal cancer: trials that stopped early
Trials on Colorectal cancer that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.
Stopped early
254 stopped trials give a reason in the registry, latest registry update first. 4 more give no reason and are not listed.
Terminated
A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors
Reason given in the registry “Corporate decision”
Quoted unchanged from ClinicalTrials.gov; record updated 8 May 2024.
- Ended
- Apr 2024
- Phase
- Phase 1/2
- Run by
- Medikine, Inc.
- Registry record
- NCT05716295
Terminated
First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer
Reason given in the registry “Strategy adjustment”
Quoted unchanged from ClinicalTrials.gov; record updated 30 Apr 2024.
- Ended
- Apr 2024
- Phase
- Phase 2
- Run by
- Binhui Biopharmaceutical Co., Ltd.
- Registry record
- NCT05648006
Withdrawn
Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)
Reason given in the registry “0 participant accrual”
Quoted unchanged from ClinicalTrials.gov; record updated 29 Apr 2024.
- Ended
- Feb 2024
- Phase
- Phase 2
- Run by
- M.D. Anderson Cancer Center
- Registry record
- NCT05900648
Terminated
TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)
Reason given in the registry “failure to accrue”
Quoted unchanged from ClinicalTrials.gov; record updated 26 Apr 2024.
- Ended
- Apr 2024
- Phase
- Phase 1
- Run by
- Abramson Cancer Center at Penn Medicine
- Registry record
- NCT04873895
Terminated
"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.
Reason given in the registry “Suspicion of adverse events”
Quoted unchanged from ClinicalTrials.gov; record updated 24 Apr 2024.
- Ended
- Apr 2024
- Run by
- Helse Stavanger HF
- Registry record
- NCT03402477
Terminated
Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact
Reason given in the registry “Difficulty enrolling and we lost exercise specialist”
Quoted unchanged from ClinicalTrials.gov; record updated 17 Apr 2024.
- Ended
- Dec 2023
- Run by
- Milton S. Hershey Medical Center
- Registry record
- NCT04731441
Withdrawn
Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer
Reason given in the registry “Sponsor already published research that was to be obtained from this study.”
Quoted unchanged from ClinicalTrials.gov; record updated 12 Apr 2024.
- Ended
- Jun 2024
- Run by
- Case Comprehensive Cancer Center
- Registry record
- NCT05356585
Suspended
DNX-2440 for Resectable Colorectal Liver Metastasis
Reason given in the registry “DNAtrix management decision not based on study design, safety, or site performance.”
Quoted unchanged from ClinicalTrials.gov; record updated 9 Apr 2024.
- Phase
- Phase 1
- Run by
- DNAtrix, Inc.
- Registry record
- NCT04714983
Suspended
Point of Care, Real-Time Urine Metabolomics Test to Diagnose Colorectal Cancers and Polyps in Low-and Middle-Income Countries
Reason given in the registry “The urine POC device seems not to be promising in colorectal cancer screening”
Quoted unchanged from ClinicalTrials.gov; record updated 5 Apr 2024.
- Ended
- Mar 2025
- Run by
- Obafemi Awolowo University Teaching Hospital
- Registry record
- NCT05679960
Withdrawn
The Effects of Chiropractic in Adults With Colon Cancer
Reason given in the registry “Low recruitment rate”
Quoted unchanged from ClinicalTrials.gov; record updated 3 Apr 2024.
- Ended
- Mar 2025
- Run by
- Life University
- Registry record
- NCT05310565
Withdrawn
#CuttingCRC: Barbershop-Based Trial & Colorectal Cancer
Reason given in the registry “PI no longer employed at institutuion”
Quoted unchanged from ClinicalTrials.gov; record updated 22 Mar 2024.
- Ended
- Feb 2024
- Run by
- Medical College of Wisconsin
- Registry record
- NCT03733197
Terminated
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Reason given in the registry “sponsor decision”
Quoted unchanged from ClinicalTrials.gov; record updated 8 Mar 2024.
- Ended
- Mar 2024
- Phase
- Phase 1
- Run by
- HiberCell, Inc.
- Registry record
- NCT05121948
Withdrawn
Medial Border of Laparoscopic D3 Lymphadenectomy for Right Colon Cancer
Reason given in the registry “no funds”
Quoted unchanged from ClinicalTrials.gov; record updated 26 Feb 2024.
- Ended
- Oct 2025
- Run by
- Shanghai Minimally Invasive Surgery Center
- Registry record
- NCT04518449
Terminated
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
Reason given in the registry “Sponsor decision (not due to safety concerns)”
Quoted unchanged from ClinicalTrials.gov; record updated 30 Jan 2024.
- Ended
- Jan 2024
- Phase
- Phase 1
- Run by
- Stingthera, Inc.
- Registry record
- NCT04609579
Withdrawn
Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal Cancer
Reason given in the registry “Inadequate patient enrollment”
Quoted unchanged from ClinicalTrials.gov; record updated 3 Jan 2024.
- Ended
- Dec 2024
- Phase
- Phase 2
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Registry record
- NCT03193814
Suspended
Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer
Reason given in the registry “Inadequate patient enrollment”
Quoted unchanged from ClinicalTrials.gov; record updated 3 Jan 2024.
- Ended
- Dec 2023
- Phase
- Phase 1/2
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Registry record
- NCT04558684
Withdrawn
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Reason given in the registry “Issues recruiting”
Quoted unchanged from ClinicalTrials.gov; record updated 22 Dec 2023.
- Ended
- Sept 2026
- Phase
- Early phase 1
- Run by
- Roswell Park Cancer Institute
- Registry record
- NCT04870034
Withdrawn
A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)
Reason given in the registry “This clinical trial was not finally approved by the Korea FDA.”
Quoted unchanged from ClinicalTrials.gov; record updated 31 Oct 2023.
- Ended
- Aug 2024
- Phase
- Phase 1/2
- Run by
- Korean Cancer Study Group
- Registry record
- NCT04751955
Withdrawn
CPI-613 (Devimistat) in Combination With Modified FOLFIRINOX Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
Reason given in the registry “no funding”
Quoted unchanged from ClinicalTrials.gov; record updated 13 Sept 2023.
- Ended
- Nov 2024
- Phase
- Phase 1
- Run by
- Cornerstone Pharmaceuticals
- Registry record
- NCT05070104
Suspended
Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)
Reason given in the registry “Too slow speed for recruiting.”
Quoted unchanged from ClinicalTrials.gov; record updated 29 Jun 2023.
- Run by
- Shenzhen People's Hospital
- Registry record
- NCT03743428
Withdrawn
Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers
Reason given in the registry “Study never started/ will not proceed.”
Quoted unchanged from ClinicalTrials.gov; record updated 7 Jun 2023.
- Ended
- Apr 2025
- Phase
- Phase 2
- Run by
- Translational Research in Oncology
- Registry record
- NCT05582031
Withdrawn
Gastrointestinal Anastomosis Using MonoPlus® Suture
Reason given in the registry “The GASTROMO study has been stopped early before enrolling its first patient because the results of our primary endpoint would have been inconsistent. The variability of the leakage rate between all anastomosis included in the study was overly high.”
Quoted unchanged from ClinicalTrials.gov; record updated 5 Apr 2023.
- Ended
- Dec 2023
- Run by
- Aesculap AG
- Registry record
- NCT04811833
Withdrawn
Predicting Risk for Post-polypectomy Colorectal Cancer
Reason given in the registry “Alternative method of implementation, study not needed”
Quoted unchanged from ClinicalTrials.gov; record updated 28 Feb 2023.
- Ended
- Dec 2023
- Run by
- Kaiser Permanente
- Registry record
- NCT05606081
Suspended
Guangzhou Women's Health Cohort Study (GWHCS)
Reason given in the registry “Due to the rebound of the COVID-19 epidemic in the city, we have to suspend the project temporarily.”
Quoted unchanged from ClinicalTrials.gov; record updated 23 Feb 2023.
- Ended
- Aug 2026
- Run by
- Guangzhou Women and Children's Medical Center
- Registry record
- NCT05506800
Withdrawn
Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors
Reason given in the registry “Similar clinical trials showed not very encouraging results, which made us decide, after several modifications to the protocol and numerous difficulties encountered, to abandon the trial.”
Quoted unchanged from ClinicalTrials.gov; record updated 26 Jan 2023.
- Ended
- Dec 2024
- Phase
- Phase 2
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
- Registry record
- NCT03982173
Suspended
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
Reason given in the registry “The efficacy evaluation (based on current data) deviated too much from results of previous clinical trials. It's assumed that high dropout rate of subjects, mainly due to covid-19 epidemic in China in the past 3 years, is the main reason.”
Quoted unchanged from ClinicalTrials.gov; record updated 10 Jan 2023.
- Ended
- Dec 2024
- Phase
- Phase 2
- Run by
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Registry record
- NCT03906565
Withdrawn
Local Consolidative Therapy in Colorectal Cancer
Reason given in the registry “Study is being closed due to lack of accrual”
Quoted unchanged from ClinicalTrials.gov; record updated 9 Dec 2022.
- Ended
- Oct 2025
- Phase
- Phase 2
- Run by
- Fox Chase Cancer Center
- Registry record
- NCT05062720
Withdrawn
Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic
Reason given in the registry “The study was never started due to lack of staff”
Quoted unchanged from ClinicalTrials.gov; record updated 29 Nov 2022.
- Ended
- Dec 2023
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
- Registry record
- NCT04964596
Withdrawn
A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
Reason given in the registry “Study drug not available for the study duration.”
Quoted unchanged from ClinicalTrials.gov; record updated 4 Nov 2022.
- Phase
- Phase 2
- Run by
- NSABP Foundation Inc
- Registry record
- NCT05178576
Withdrawn
Improving Survivorship Among Minority Cancer Dyads
Reason given in the registry “Study not funded”
Quoted unchanged from ClinicalTrials.gov; record updated 26 Jul 2022.
- Ended
- Dec 2024
- Run by
- Charles Drew University of Medicine and Science
- Registry record
- NCT04685551
Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.